Back to search

South Dakota State University

Evaluation of the Effect of Carvedilol on the Thioredoxin Pathway in H9C2 Rat Cardiomyocytes

Abstract

dc:description.abstract

The thioredoxin (Trx) system is an endogenous antioxidant system that affects cell function and survival through controlling cellular redox status. Trx and TrxR are the main enzymes in this system while thioredoxin interacting protein (TXNIP) is a negative regulator. This study’s goal was to better understand the Trx system’s involvement in the cardiovascular disease and modulate the pathway through drug treatment. Carvedilol is a non-selective β-blocker that also exhibits antioxidant properties, but the exact mechanism of the antioxidant effect is still unclear. H9c2 rat cardiomyocytes were used to examine the effect of carvedilol on the Trx system under normal conditions. Interestingly, carvedilol was able to decrease TXNIP not through its expression or proteasomal degradation but through increased TXNIP nuclear localization. Immunoprecipitation also showed an increase in TXNIP-PARP complexation in the nucleus and a decrease in Trx-TXNIP complexation in the cytosol. The results indicate that carvedilol may exhibit its antioxidant activity through altering TXNIP subcellular localization. TXNIP is known to be important in both physiologic and pathophysiologic conditions. Western blot data showed that TXNIP in the cytosol will increase with increasing glucose concentration. Oxidative stress inducers such as doxorubicin, hypoxiareoxygenation, and radiation were able to decrease cytosolic TXNIP. Doxorubicin is a commonly utilized anticancer drug that induces oxidative stress and therefore causes cardiac toxicity. A study was conducted to determine if carvedilol could protect against doxorubicin-induced cardiotoxicity through TXNIP modulation. Carvedilol and doxorubicin alone reduced cytosolic TXNIP. Doxorubicin increased mitochondrial translocation of TXNIP accompanied by the induction of apoptosis. However, carvedilol was not able to prevent TXNIP mitochondrial translocation, but it did protect against doxorubicin-induced apoptosis. The complex of Trx2 and the proapoptotic ASK1 in the mitochondria was increased with carvedilol pretreatment followed by doxorubicin exposure. The increase in the ASK1-Trx2 complex can reduce apoptosis through decreased ASK1 activation. This was confirmed through Western blot of cleaved PARP. The findings are consistent with reports of TXNIP’s response to mild oxidative stress conditions. In conclusion, this study shows for the first time that carvedilol impacts TXNIP localization and complexation and that the Trx pathway may be involved in carvedilol’s observed cardioprotective effect.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Dissertation - Open Access
Discipline thesis:degree_discipline
Pharmaceutical Sciences

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Alharbi, Metab
Contributors dc:contributor
  • Teresa Seefeldt

Subjects

dc:subject × 1

Rights

dc:rights

Identifiers

dc:identifier.*
Repository record dc:identifier
https://openprairie.sdstate.edu/etd/3179

Chain of custody

source
Harvested from
South Dakota State University
Base URL
openprairie.sdstate.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Alharbi, Metab. Evaluation of the Effect of Carvedilol on the Thioredoxin Pathway in H9C2 Rat Cardiomyocytes. Dissertation - Open Access thesis, https://openprairie.sdstate.edu/etd/3179